152 related articles for article (PubMed ID: 33090711)
1. Enhanced DNA damage response through RAD50 in triple negative breast cancer resistant and cancer stem-like cells contributes to chemoresistance.
Abad E; Civit L; Potesil D; Zdrahal Z; Lyakhovich A
FEBS J; 2021 Apr; 288(7):2184-2202. PubMed ID: 33090711
[TBL] [Abstract][Full Text] [Related]
2. Aberrations of the MRE11-RAD50-NBS1 DNA damage sensor complex in human breast cancer: MRE11 as a candidate familial cancer-predisposing gene.
Bartkova J; Tommiska J; Oplustilova L; Aaltonen K; Tamminen A; Heikkinen T; Mistrik M; Aittomäki K; Blomqvist C; Heikkilä P; Lukas J; Nevanlinna H; Bartek J
Mol Oncol; 2008 Dec; 2(4):296-316. PubMed ID: 19383352
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of the MRE11-RAD50-NBS1 (MRN) complex in rectal cancer correlates with poor response to neoadjuvant radiotherapy and prognosis.
Ho V; Chung L; Singh A; Lea V; Abubakar A; Lim SH; Ng W; Lee M; de Souza P; Shin JS; Lee CS
BMC Cancer; 2018 Sep; 18(1):869. PubMed ID: 30176843
[TBL] [Abstract][Full Text] [Related]
4. MRN (MRE11-RAD50-NBS1) Complex in Human Cancer and Prognostic Implications in Colorectal Cancer.
Situ Y; Chung L; Lee CS; Ho V
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30769804
[TBL] [Abstract][Full Text] [Related]
5. The ends in sight: Mre11-Rad50-Nbs1 complex structures come into focus.
Wojtaszek JL; Williams RS
Mol Cell; 2023 Jan; 83(2):160-162. PubMed ID: 36669476
[TBL] [Abstract][Full Text] [Related]
6. C1QBP Promotes Homologous Recombination by Stabilizing MRE11 and Controlling the Assembly and Activation of MRE11/RAD50/NBS1 Complex.
Bai Y; Wang W; Li S; Zhan J; Li H; Zhao M; Zhou XA; Li S; Li X; Huo Y; Shen Q; Zhou M; Zhang H; Luo J; Sung P; Zhu WG; Xu X; Wang J
Mol Cell; 2019 Sep; 75(6):1299-1314.e6. PubMed ID: 31353207
[TBL] [Abstract][Full Text] [Related]
7. Loss of the tumor suppressor BIN1 enables ATM Ser/Thr kinase activation by the nuclear protein E2F1 and renders cancer cells resistant to cisplatin.
Folk WP; Kumari A; Iwasaki T; Pyndiah S; Johnson JC; Cassimere EK; Abdulovic-Cui AL; Sakamuro D
J Biol Chem; 2019 Apr; 294(14):5700-5719. PubMed ID: 30733337
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer risk is associated with the genes encoding the DNA double-strand break repair Mre11/Rad50/Nbs1 complex.
Hsu HM; Wang HC; Chen ST; Hsu GC; Shen CY; Yu JC
Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):2024-32. PubMed ID: 17932350
[TBL] [Abstract][Full Text] [Related]
9. Molecular disruption of RAD50 sensitizes human tumor cells to cisplatin-based chemotherapy.
Abuzeid WM; Jiang X; Shi G; Wang H; Paulson D; Araki K; Jungreis D; Carney J; O'Malley BW; Li D
J Clin Invest; 2009 Jul; 119(7):1974-85. PubMed ID: 19487811
[TBL] [Abstract][Full Text] [Related]
10. ATM and the Mre11-Rad50-Nbs1 complex respond to nucleoside analogue-induced stalled replication forks and contribute to drug resistance.
Ewald B; Sampath D; Plunkett W
Cancer Res; 2008 Oct; 68(19):7947-55. PubMed ID: 18829552
[TBL] [Abstract][Full Text] [Related]
11. SPRTN protease-cleaved MRE11 decreases DNA repair and radiosensitises cancer cells.
Na J; Newman JA; Then CK; Syed J; Vendrell I; Torrecilla I; Ellermann S; Ramadan K; Fischer R; Kiltie AE
Cell Death Dis; 2021 Feb; 12(2):165. PubMed ID: 33558481
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin-induced cell death increases the degradation of the MRE11-RAD50-NBS1 complex through the autophagy/lysosomal pathway.
Belmonte-Fernández A; Herrero-Ruíz J; Galindo-Moreno M; Limón-Mortés MC; Mora-Santos M; Sáez C; Japón MÁ; Tortolero M; Romero F
Cell Death Differ; 2023 Feb; 30(2):488-499. PubMed ID: 36477079
[TBL] [Abstract][Full Text] [Related]
13. SMAD3 silencing enhances DNA damage in radiation therapy by interacting with MRE11-RAD50-NBS1 complex in glioma.
Jiang Z; Guo Y; Miao L; Han L; Zhang W; Jiang Y
J Biochem; 2019 Apr; 165(4):317-322. PubMed ID: 30535026
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer risk associated with genes encoding DNA repair MRN complex: a study from Punjab, Pakistan.
Khan RT; Siddique A; Shahid N; Khokher S; Fatima W
Breast Cancer; 2018 May; 25(3):350-355. PubMed ID: 29368209
[TBL] [Abstract][Full Text] [Related]
15. Human RAD50 deficiency: Confirmation of a distinctive phenotype.
Ragamin A; Yigit G; Bousset K; Beleggia F; Verheijen FW; de Wit MY; Strom TM; Dörk T; Wollnik B; Mancini GMS
Am J Med Genet A; 2020 Jun; 182(6):1378-1386. PubMed ID: 32212377
[TBL] [Abstract][Full Text] [Related]
16. Integrative Expression, Survival Analysis and Cellular miR-2909 Molecular Interplay in MRN Complex Check Point Sensor Genes (MRN-CSG) Involved in Breast Cancer.
Singh J; Sangwan N; Chauhan A; Avti PK
Clin Breast Cancer; 2022 Dec; 22(8):e850-e862. PubMed ID: 36220723
[TBL] [Abstract][Full Text] [Related]
17. Envisioning the dynamics and flexibility of Mre11-Rad50-Nbs1 complex to decipher its roles in DNA replication and repair.
Lafrance-Vanasse J; Williams GJ; Tainer JA
Prog Biophys Mol Biol; 2015 Mar; 117(2-3):182-193. PubMed ID: 25576492
[TBL] [Abstract][Full Text] [Related]
18. Involvement of ATMIN-DYNLL1-MRN axis in the progression and aggressiveness of serous ovarian cancer.
Berkel C; Cacan E
Biochem Biophys Res Commun; 2021 Sep; 570():74-81. PubMed ID: 34273621
[TBL] [Abstract][Full Text] [Related]
19. MRE11-RAD50-NBS1 promotes Fanconi Anemia R-loop suppression at transcription-replication conflicts.
Chang EY; Tsai S; Aristizabal MJ; Wells JP; Coulombe Y; Busatto FF; Chan YA; Kumar A; Dan Zhu Y; Wang AY; Fournier LA; Hieter P; Kobor MS; Masson JY; Stirling PC
Nat Commun; 2019 Sep; 10(1):4265. PubMed ID: 31537797
[TBL] [Abstract][Full Text] [Related]
20. Replication protein A and the Mre11.Rad50.Nbs1 complex co-localize and interact at sites of stalled replication forks.
Robison JG; Elliott J; Dixon K; Oakley GG
J Biol Chem; 2004 Aug; 279(33):34802-10. PubMed ID: 15180989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]